The field report
436

THE CLINIC

SECTION 12

ISSUE 001

PROJECTIONproduct1-3yconfidence / low

Trial Matching at Encounter Time

Projection: Clinical documentation and evidence-tool uptake suggest that eligibility screening could surface while a patient is still being seen, but they do not show this happening. The mechanism earns confidence only if qualified trial referrals increase without a parallel increase in unsuitable enrollment suggestions.

Why this idea is here

What the evidence establishes.

The cited captures document clinical documentation and evidence-tool adoption. They do not establish Trial Matching at Encounter Time as a deployed mechanism. The adoption test is whether encounter-time matching increases eligible trial referrals without inappropriate enrollment suggestions.

Source ledger

Read the sources.

  1. S01
    Abridge Customer Deployments

    company customer evidence / published 2026-04-17 / retrieved 2026-07-09

  2. S02
    OpenEvidence doubles valuation to $12 billion

    independent reporting / published 2026-01-21 / retrieved 2026-07-09

  3. S03
    Economy | The 2026 AI Index Report

    academic index / dated 2026-04 / retrieved 2026-07-10

  4. S04
    EIOPA survey on Generative AI adoption among insurers

    regulator survey / published 2026-02-02 / retrieved 2026-07-09

Back to all 500 ideas